Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)

Clinical trial NCT04259255 · COMPLETED

Trial details

NCT number: NCT04259255
Sponsor: Shionogi
Status: COMPLETED
Study type: OBSERVATIONAL

Amyotrophic Lateral Sclerosis ALS

Start date: 2019-10-21
Primary completion: 2023-11-24
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.